Ophthalmology CRO Services
KCAS Bio has experience in preclinical ophthalmic research, ranging from identification and procurement of compounds to determining efficacy, tolerability, and PK studies. We give you the milestone data you need to make important decisions in the early stages of your ophthalmologic product development.
Complex ophthalmology studies demand specialist expertise
When developing products for the eye, your project needs a CRO with specialist experience and expertise. Many studies in ophthalmology are complex, and for this reason you need a team which understands the assessments and can focus on the details. KCAS Bio knows how to provide high quality data for your ophthalmology drug development project.
Ophthalmology treatment research, by leading scientists
There are a couple major challenges typically associated with ophthalmology as it relates to bioanalysis, one of the main being limited access to fluids or tissues from a living eye. It is difficult to develop highly sensitive methods when you can’t use a lot of the matrix available. At KCAS Bio, we have a rich history of conducting studies on eye tissues and using unique techniques that make a little sample go a long way in our processes. We have leveraged our rich history of knowing how to build a sensitive method with a minimal amount of volume. Additionally, our pharma team has become well-known for their PK analysis of small molecules, which makes us a perfect candidate for ophthalmological studies, as typically the treatment of the eye is a small molecule.
We employ rigorous quality practices that go beyond our competition. Processes are continuously improved to ensure we consistently deliver a complete outsourcing experience to clients.
KCAS Bio provides high quality science and data services that have benefits for the entire drug development journey.
Agile, responsive, and easy to work with
We prepare and adapt our ophthalmology research based on a deep understanding of your drug development ambitions and wider business objectives.
KCAS Bio scientific insights
News
Strengthening scientific reporting, data integrity, and laboratory workflows through technology and automation. Drug development is becoming more complex. Bioanalytical laboratories need efficient workflows, reliable data, and clear reporting to support this work. KCAS Bio is investing in technology to strengthen these capabilities. Through a new partnership with…
Blogs
Drug development does not happen in discrete stages. Yet molecular bioanalysis is often managed as though it does. A molecular assay may begin in a preclinical environment under Good Laboratory Practice (GLP), then transition to a different laboratory, team, or quality framework when clinical development begins. While this…
Podcasts
In this special VIDEO episode of “The Weekly Bioanalysis”, our experts, Dawn Dufield and Lindsay Rutherford have captured episode #103 LIVE and onsite in New Orleans during AAPS PharmSci360! They discuss all the things they have done during the conference and thank customers who were able to stop by…
Tell us how we can help with your project
We've earned our reputation for delivering reliable, error-free data. We understand the importance of speed, flexibility, and consistency and only make promises we can keep.